Science Applications International (SAIC)
(Delayed Data from NYSE)
$104.86 USD
-0.50 (-0.47%)
Updated Sep 26, 2023 04:00 PM ET
After-Market: $104.85 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Balance Sheet
Fiscal Year End for Science Applications International Corporation falls in the month of January.
All items in Millions except Per Share data.
1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 | 1/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 109 | 106 | 171 | 188 | 237 |
Receivables | 936 | 1,015 | 962 | 1,099 | 1,050 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 71 | 64 | 78 | 84 | 74 |
Other Current Assets | 81 | 78 | 78 | 59 | 72 |
Total Current Assets | 1,197 | 1,263 | 1,289 | 1,430 | 1,433 |
Net Property & Equipment | 92 | 100 | 108 | 91 | 103 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3,920 | 4,045 | 3,925 | 2,850 | 2,923 |
Deposits & Other Assets | 176 | 129 | 165 | 150 | 104 |
Total Assets | 5,543 | 5,746 | 5,723 | 4,711 | 4,563 |
Liabilities & Shareholders Equity | 1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 | 1/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 624 | 612 | 517 | 527 | 455 |
Current Portion Long-Term Debt | 31 | 148 | 68 | 70 | 24 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 471 | 592 | 690 | 531 | 418 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 1,126 | 1,352 | 1,275 | 1,128 | 897 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 43 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,343 | 2,370 | 2,447 | 1,851 | 2,065 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 218 | 160 | 244 | 133 | 102 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3,839 | 4,117 | 4,171 | 3,284 | 3,064 |
Shareholders Equity | 1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 | 1/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 637 | 838 | 1,004 | 983 | 1,132 |
Retained Earnings | 1,035 | 818 | 627 | 506 | 367 |
Other Equity | 32 | -27 | -79 | -62 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 1,704 | 1,629 | 1,552 | 1,427 | 1,499 |
Total Liabilities & Shareholder's Equity | 5,543 | 5,746 | 5,723 | 4,711 | 4,563 |
Total Common Equity | 1,704 | 1,629 | 1,552 | 1,427 | 1,499 |
Shares Outstanding | 54.60 | 56.90 | 58.20 | 57.70 | 60.00 |
Book Value Per Share | 31.21 | 28.63 | 26.67 | 24.73 | 24.98 |
Fiscal Year End for Science Applications International Corporation falls in the month of January.
All items in Millions except Per Share data.
7/31/2023 | 4/30/2023 | 1/31/2023 | 10/31/2022 | 7/31/2022 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 352 | 422 | 109 | 53 | 99 |
Receivables | 958 | 995 | 936 | 1,059 | 1,036 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 74 | 77 | 71 | 135 | 135 |
Other Current Assets | 0 | 181 | 81 | 0 | 0 |
Total Current Assets | 1,384 | 1,675 | 1,197 | 1,247 | 1,270 |
Net Property & Equipment | 90 | 91 | 92 | 95 | 95 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3,802 | 3,831 | 3,920 | 3,951 | 3,980 |
Deposits & Other Assets | 256 | 206 | 176 | 169 | 136 |
Total Assets | 5,672 | 5,957 | 5,543 | 5,628 | 5,654 |
Liabilities & Shareholders Equity | 7/31/2023 | 4/30/2023 | 1/31/2023 | 10/31/2022 | 7/31/2022 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 820 | 809 | 624 | 819 | 853 |
Current Portion Long-Term Debt | 62 | 46 | 31 | 15 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 330 | 277 | 471 | 396 | 337 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 421 | 0 | 0 | 0 |
Total Current Liabilities | 1,212 | 1,553 | 1,126 | 1,230 | 1,190 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 7 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,215 | 2,329 | 2,343 | 2,358 | 2,462 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 264 | 218 | 189 | 180 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3,829 | 4,265 | 3,839 | 3,932 | 4,001 |
Shareholders Equity | 7/31/2023 | 4/30/2023 | 1/31/2023 | 10/31/2022 | 7/31/2022 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 480 | 563 | 637 | 679 | 723 |
Retained Earnings | 1,340 | 1,113 | 1,035 | 981 | 923 |
Other Equity | 23 | 16 | 32 | 36 | 7 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 1,843 | 1,692 | 1,704 | 1,696 | 1,653 |
Total Liabilities & Shareholder's Equity | 5,672 | 5,957 | 5,543 | 5,628 | 5,654 |
Total Common Equity | 1,843 | 1,692 | 1,704 | 1,696 | 1,653 |
Shares Outstanding | 52.90 | 53.60 | 54.60 | 54.60 | 55.10 |
Book Value Per Share | 34.84 | 31.57 | 31.21 | 31.06 | 30.00 |